<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03384173</url>
  </required_header>
  <id_info>
    <org_study_id>2017-0589</org_study_id>
    <secondary_id>207-013</secondary_id>
    <secondary_id>A536757</secondary_id>
    <secondary_id>SMPH/PEDIATRICS/PEDIATRICS</secondary_id>
    <nct_id>NCT03384173</nct_id>
  </id_info>
  <brief_title>NIRS Monitoring to Detect AKI in Preterm Infants</brief_title>
  <acronym>nNIRS-AKI</acronym>
  <official_title>Use of NIRS to Detect Acute Kidney Injury in Preterm Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the relationship of oxygen levels, using Near-infrared spectroscopy&#xD;
      (NIRS) monitoring, and kidney injury in infants born prematurely. NIRS is a skin sensor which&#xD;
      detects the amount of oxygen going to different organs, most often used to monitor the brain&#xD;
      and kidney.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective, single-center study was conducted at UnityPoint Health-Meriter Hospital&#xD;
      (Madison, WI, USA) in preterm neonates admitted to a level III NICU from April 2018 to August&#xD;
      2019. The primary study aim was to assess changes in RrSO2 with continuous renal NIRS&#xD;
      monitoring to detect AKI during the first 7 days of age.&#xD;
&#xD;
      The INVOS 5100 C (Somanetics, Troy, MI, USA) four channel NIRS monitors were used to measure&#xD;
      RrSO2 (measured at the right or left flank) and Cerebral regional Somatic tissue Oxygenation&#xD;
      (CrSO2; measured at the forehead) for all neonates. At each measurement site, for skin&#xD;
      protection, subjects had a transparent Mepitel (with Safetac Technology, Norcross, GA)&#xD;
      adhesive dressing placed with the adhesive neonatal NIRS sensor (INVOS OxyAlert NIRSensor,&#xD;
      Covidien) adhered over the Mepitel dressing. Neither cerebral or kidney sensors were placed&#xD;
      with ultrasound guidance. Tissue oxygenation was recorded every 3 seconds until 7 days of&#xD;
      age, and the sensor was changed one time when the patient reached three to four days of age&#xD;
      per the company's recommendation. There were no restrictions on positioning or handling of&#xD;
      neonates; nurses re-positioned neonates every 3-6 hours per unit protocol to prevent skin&#xD;
      pressure injuries. Researchers, staff, and parents were blinded to RrSO2 values.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 25, 2018</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Renal NIRS Tissue Oxygenation Differential</measure>
    <time_frame>Up to 1 week</time_frame>
    <description>Comparison of Renal saturation (Rsat) in neonates with AKI to those without AKI. RSO2 will be recorded until 7 days of age. Median RSO2 for 1 week and median for individual days 2-7 will be calculated.&#xD;
The INVOS 5100 C (Somanetics, Troy, MI, USA) four channel NIRS monitors will be used to measure renal regional oxygenation (RrSO2) values for all neonates.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation of Renal NIRS Values to Serum Creatinine</measure>
    <time_frame>Days 1-7 of age</time_frame>
    <description>At each time a serum creatinine was collected, the RrSO2 value was recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of Renal NIRS Values to Urine Output</measure>
    <time_frame>Days 1-7 of age</time_frame>
    <description>In patients with urine output recorded, it was compared to RrSO2 values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Renal NIRS Values Before Caffeine</measure>
    <time_frame>Baseline (6 hours prior to caffeine dose)</time_frame>
    <description>these are the average renal NIRS values over 6 hours prior to a dose of caffeine broken down by percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal NIRS Values 1 Hour After Caffeine</measure>
    <time_frame>At 1 hour after caffeine dose</time_frame>
    <description>Renal NIRS values one hour after caffeine broken down by baseline average.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal NIRS Values 2 Hours After Caffeine</measure>
    <time_frame>At 2 hours after caffeine dose</time_frame>
    <description>Renal NIRS values 2 hours after caffeine broken down by baseline average</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal NIRS Values 3 Hours After Caffeine</measure>
    <time_frame>At 3 hours after caffeine dose</time_frame>
    <description>Renal NIRS values 3 hours after caffeine broken down by baseline average</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal NIRS Values 4 Hours After Caffeine</measure>
    <time_frame>At 4 hours after caffeine dose</time_frame>
    <description>Renal NIRS values 4 hours after caffeine broken down by baseline average</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal NIRS Values 6 Hours After Caffeine</measure>
    <time_frame>At 6 hours after caffeine dose</time_frame>
    <description>Renal NIRS values 6 hours after caffeine broken down by baseline average</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Acute Kidney Injury</condition>
  <condition>Premature Infant</condition>
  <arm_group>
    <arm_group_label>NIRS monitoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>These infants will be monitored with NIRS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Near Infrared Spectroscopy</intervention_name>
    <description>Application of regional NIRS sensors to brain and kidney sites in the first 48 hours after birth to monitor regional tissue oxygenation for the first 7 days of age.</description>
    <arm_group_label>NIRS monitoring</arm_group_label>
    <other_name>NIRS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Preterm infants &lt; 32 weeks&#xD;
&#xD;
          -  Admitted to Unity Point Health(UPH) Meriter Newborn Intensive Care Unit (NICU)&#xD;
&#xD;
          -  Application of NIRS by 48 hours of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Congenital anomaly of the kidney or urinary tract (CAKUT)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew W Harer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin, Madison</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UnityPoint Health Meriter Hospital</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53715-1507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Chock VY, Rose LA, Mante JV, Punn R. Near-infrared spectroscopy for detection of a significant patent ductus arteriosus. Pediatr Res. 2016 Nov;80(5):675-680. doi: 10.1038/pr.2016.148. Epub 2016 Sep 7.</citation>
    <PMID>27603562</PMID>
  </reference>
  <reference>
    <citation>Ruf B, Bonelli V, Balling G, HÃ¶rer J, Nagdyman N, Braun SL, Ewert P, Reiter K. Intraoperative renal near-infrared spectroscopy indicates developing acute kidney injury in infants undergoing cardiac surgery with cardiopulmonary bypass: a case-control study. Crit Care. 2015 Jan 29;19:27. doi: 10.1186/s13054-015-0760-9.</citation>
    <PMID>25631390</PMID>
  </reference>
  <reference>
    <citation>Hazle MA, Gajarski RJ, Aiyagari R, Yu S, Abraham A, Donohue J, Blatt NB. Urinary biomarkers and renal near-infrared spectroscopy predict intensive care unit outcomes after cardiac surgery in infants younger than 6 months of age. J Thorac Cardiovasc Surg. 2013 Oct;146(4):861-867.e1. doi: 10.1016/j.jtcvs.2012.12.012. Epub 2013 Jan 12.</citation>
    <PMID>23317940</PMID>
  </reference>
  <reference>
    <citation>Owens GE, King K, Gurney JG, Charpie JR. Low renal oximetry correlates with acute kidney injury after infant cardiac surgery. Pediatr Cardiol. 2011 Feb;32(2):183-8. doi: 10.1007/s00246-010-9839-x. Epub 2010 Nov 19.</citation>
    <PMID>21085945</PMID>
  </reference>
  <reference>
    <citation>McNeill S, Gatenby JC, McElroy S, Engelhardt B. Normal cerebral, renal and abdominal regional oxygen saturations using near-infrared spectroscopy in preterm infants. J Perinatol. 2011 Jan;31(1):51-7. doi: 10.1038/jp.2010.71. Epub 2010 Jun 10.</citation>
    <PMID>20539273</PMID>
  </reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 15, 2017</study_first_submitted>
  <study_first_submitted_qc>December 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 27, 2017</study_first_posted>
  <results_first_submitted>September 28, 2020</results_first_submitted>
  <results_first_submitted_qc>December 15, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 21, 2020</results_first_posted>
  <last_update_submitted>December 15, 2020</last_update_submitted>
  <last_update_submitted_qc>December 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Near Infrared Spectroscopy</keyword>
  <keyword>Creatinine</keyword>
  <keyword>Urine Output</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 23, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/73/NCT03384173/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>NIRS Monitoring</title>
          <description>These infants will be monitored with NIRS&#xD;
Near Infrared Spectroscopy: Application of regional NIRS sensors to brain and kidney sites in the first 48 hours after birth to monitor regional tissue oxygenation for the first 7 days of age.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>No Acute Kidney Injury (AKI)</title>
          <description>Infants with No AKI diagnosis.&#xD;
These infants will be monitored with NIRS&#xD;
Near Infrared Spectroscopy: Application of regional NIRS sensors to brain and kidney sites in the first 48 hours after birth to monitor regional tissue oxygenation for the first 7 days of age.</description>
        </group>
        <group group_id="B2">
          <title>Acute Kidney Injury (AKI)</title>
          <description>Infants diagnosed with AKI.&#xD;
These infants will be monitored with NIRS&#xD;
Near Infrared Spectroscopy: Application of regional NIRS sensors to brain and kidney sites in the first 48 hours after birth to monitor regional tissue oxygenation for the first 7 days of age.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="32"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="35"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>gestational age (weeks)</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.4" lower_limit="26.9" upper_limit="30.6"/>
                    <measurement group_id="B2" value="25" lower_limit="23" upper_limit="27.3"/>
                    <measurement group_id="B3" value="27.2" lower_limit="23" upper_limit="30.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Small for gestational age</title>
          <description>Small for gestational age defined as &lt;10% for birthweight on the Fenton Growth Chart.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Birth Weight</title>
          <units>grams</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1135" lower_limit="823" upper_limit="1490"/>
                    <measurement group_id="B2" value="655" lower_limit="485" upper_limit="1020"/>
                    <measurement group_id="B3" value="945" lower_limit="485" upper_limit="1490"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Renal NIRS Tissue Oxygenation Differential</title>
        <description>Comparison of Renal saturation (Rsat) in neonates with AKI to those without AKI. RSO2 will be recorded until 7 days of age. Median RSO2 for 1 week and median for individual days 2-7 will be calculated.&#xD;
The INVOS 5100 C (Somanetics, Troy, MI, USA) four channel NIRS monitors will be used to measure renal regional oxygenation (RrSO2) values for all neonates.</description>
        <time_frame>Up to 1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>No Acute Kidney Injury (AKI)</title>
            <description>Infants with No AKI diagnosis.&#xD;
These infants will be monitored with NIRS&#xD;
Near Infrared Spectroscopy: Application of regional NIRS sensors to brain and kidney sites in the first 48 hours after birth to monitor regional tissue oxygenation for the first 7 days of age.</description>
          </group>
          <group group_id="O2">
            <title>Acute Kidney Injury (AKI)</title>
            <description>Infants diagnosed with AKI.&#xD;
These infants will be monitored with NIRS&#xD;
Near Infrared Spectroscopy: Application of regional NIRS sensors to brain and kidney sites in the first 48 hours after birth to monitor regional tissue oxygenation for the first 7 days of age.</description>
          </group>
        </group_list>
        <measure>
          <title>Renal NIRS Tissue Oxygenation Differential</title>
          <description>Comparison of Renal saturation (Rsat) in neonates with AKI to those without AKI. RSO2 will be recorded until 7 days of age. Median RSO2 for 1 week and median for individual days 2-7 will be calculated.&#xD;
The INVOS 5100 C (Somanetics, Troy, MI, USA) four channel NIRS monitors will be used to measure renal regional oxygenation (RrSO2) values for all neonates.</description>
          <units>percentage saturation</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 week Median RSO2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60" lower_limit="58.4" upper_limit="62"/>
                    <measurement group_id="O2" value="32.4" lower_limit="27.9" upper_limit="47.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2 RrSO2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.5" lower_limit="59" upper_limit="65.7"/>
                    <measurement group_id="O2" value="44.4" lower_limit="39.4" upper_limit="46.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3 RrSO2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.4" lower_limit="59.3" upper_limit="61.7"/>
                    <measurement group_id="O2" value="30.8" lower_limit="28" upper_limit="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4 RrSO2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.1" lower_limit="57" upper_limit="59.9"/>
                    <measurement group_id="O2" value="29.9" lower_limit="27" upper_limit="31.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5 RrSO2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.7" lower_limit="58.4" upper_limit="61.1"/>
                    <measurement group_id="O2" value="29.2" lower_limit="25.7" upper_limit="36.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 6 RrSO2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60" lower_limit="59" upper_limit="61.3"/>
                    <measurement group_id="O2" value="24" lower_limit="20.9" upper_limit="27.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7 RrSO2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.3" lower_limit="57.8" upper_limit="66.9"/>
                    <measurement group_id="O2" value="55.3" lower_limit="39" upper_limit="58.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Correlation of Renal NIRS Values to Serum Creatinine</title>
        <description>At each time a serum creatinine was collected, the RrSO2 value was recorded.</description>
        <time_frame>Days 1-7 of age</time_frame>
        <population>All participants with serum creatinine values were included</population>
        <group_list>
          <group group_id="O1">
            <title>Infants With Serum Creatinine Values</title>
            <description>Any infant with serum creatinine values were included.</description>
          </group>
        </group_list>
        <measure>
          <title>Correlation of Renal NIRS Values to Serum Creatinine</title>
          <description>At each time a serum creatinine was collected, the RrSO2 value was recorded.</description>
          <population>All participants with serum creatinine values were included</population>
          <units>mg/dL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.81" lower_limit="0.67" upper_limit="0.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Correlation, Pearson r</non_inferiority_desc>
            <p_value>0.17</p_value>
            <method>Pearson r correlation</method>
            <param_type>Pearson r correlation</param_type>
            <param_value>0.16</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.07</ci_lower_limit>
            <ci_upper_limit>0.37</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Correlation of Renal NIRS Values to Urine Output</title>
        <description>In patients with urine output recorded, it was compared to RrSO2 values</description>
        <time_frame>Days 1-7 of age</time_frame>
        <population>All patients</population>
        <group_list>
          <group group_id="O1">
            <title>Neonates With Urine Output Recorded</title>
            <description>All neonates with urine output recorded were included</description>
          </group>
        </group_list>
        <measure>
          <title>Correlation of Renal NIRS Values to Urine Output</title>
          <description>In patients with urine output recorded, it was compared to RrSO2 values</description>
          <population>All patients</population>
          <units>mL/kg/hour</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="2.3" upper_limit="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Correlation, Pearson r</non_inferiority_desc>
            <p_value>0.32</p_value>
            <method>Pearson r correlation</method>
            <param_type>Pearson r correlation</param_type>
            <param_value>0.12</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.11</ci_lower_limit>
            <ci_upper_limit>0.33</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Renal NIRS Values Before Caffeine</title>
        <description>these are the average renal NIRS values over 6 hours prior to a dose of caffeine broken down by percentage</description>
        <time_frame>Baseline (6 hours prior to caffeine dose)</time_frame>
        <population>Out of 35 enrolled participants, 32 participants received total 156 doses of caffeine. Giving Caffeine was at the discretion of the attending physician.&#xD;
This analysis is done by the dose of caffeine, and not the participant. Each row shows the number of doses given in that baseline percentage.&#xD;
The caffeine doses have been de-identified from the participants so the number of participants in each row cannot be calculated from the currently recorded data.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline Renal NIRS Values Before Caffeine</title>
            <description>6 hour average prior to dose of caffeine</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Renal NIRS Values Before Caffeine</title>
          <description>these are the average renal NIRS values over 6 hours prior to a dose of caffeine broken down by percentage</description>
          <population>Out of 35 enrolled participants, 32 participants received total 156 doses of caffeine. Giving Caffeine was at the discretion of the attending physician.&#xD;
This analysis is done by the dose of caffeine, and not the participant. Each row shows the number of doses given in that baseline percentage.&#xD;
The caffeine doses have been de-identified from the participants so the number of participants in each row cannot be calculated from the currently recorded data.</population>
          <units>% oxygenation</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>caffeine doses</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>caffeine doses</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline &lt;20% (12 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.24" lower_limit="15.01" upper_limit="16.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline 20-29.99% (16 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.93" lower_limit="22.25" upper_limit="28.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline 30-39.99% (18 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.11" lower_limit="34.13" upper_limit="38.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline 40-49.99% (13 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.61" lower_limit="43.65" upper_limit="49.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline 50-59.99% (21 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.41" lower_limit="51.78" upper_limit="57.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline &gt;60% (76 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="76"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.08" lower_limit="66.82" upper_limit="80.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Renal NIRS Values 1 Hour After Caffeine</title>
        <description>Renal NIRS values one hour after caffeine broken down by baseline average.</description>
        <time_frame>At 1 hour after caffeine dose</time_frame>
        <population>Out of 35 enrolled participants, 32 participants received total 156 doses of caffeine. Giving Caffeine was at the discretion of the attending physician.&#xD;
This analysis is done by the dose of caffeine, and not the participant. Each row shows the number of doses given in that baseline percentage.&#xD;
The caffeine doses have been de-identified from the participants so the number of participants in each row cannot be calculated from the currently recorded data.</population>
        <group_list>
          <group group_id="O1">
            <title>NIRS Monitoring</title>
            <description>These infants will be monitored with NIRS&#xD;
Near Infrared Spectroscopy: Application of regional NIRS sensors to brain and kidney sites in the first 48 hours after birth to monitor regional tissue oxygenation for the first 7 days of age.</description>
          </group>
        </group_list>
        <measure>
          <title>Renal NIRS Values 1 Hour After Caffeine</title>
          <description>Renal NIRS values one hour after caffeine broken down by baseline average.</description>
          <population>Out of 35 enrolled participants, 32 participants received total 156 doses of caffeine. Giving Caffeine was at the discretion of the attending physician.&#xD;
This analysis is done by the dose of caffeine, and not the participant. Each row shows the number of doses given in that baseline percentage.&#xD;
The caffeine doses have been de-identified from the participants so the number of participants in each row cannot be calculated from the currently recorded data.</population>
          <units>percentage saturation</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>caffeine doses</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>caffeine doses</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Doses with baseline &lt;20% (12 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.09" lower_limit="15.1" upper_limit="17.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 20-29.99% (16 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.83" lower_limit="26.38" upper_limit="38.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 30-39.99% (18 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.18" lower_limit="34.65" upper_limit="51.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 40-49.99% (13 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.23" lower_limit="45.71" upper_limit="55.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 50-59.99% (21 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.31" lower_limit="51.51" upper_limit="60.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline &gt;60% (76 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="76"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.55" lower_limit="63.44" upper_limit="77.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Control group is Secondary analysis #4, baseline values before caffeine dose.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Mann Whitney U non parametric test</non_inferiority_desc>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>A-priori threshold p&lt;0.05 for 'subgroup 20-29.99%' vs 'baseline value before caffeine dose'.&#xD;
A-priori threshold p&lt;0.05 for 'subgroup 30-39.99%' vs 'baseline value before caffeine dose'.</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Renal NIRS Values 2 Hours After Caffeine</title>
        <description>Renal NIRS values 2 hours after caffeine broken down by baseline average</description>
        <time_frame>At 2 hours after caffeine dose</time_frame>
        <population>Out of 35 enrolled participants, 32 participants received total 156 doses of caffeine. Giving Caffeine was at the discretion of the attending physician.&#xD;
This analysis is done by the dose of caffeine, and not the participant. Each row shows the number of doses given in that baseline percentage.&#xD;
The caffeine doses have been de-identified from the participants so the number of participants in each row cannot be calculated from the currently recorded data.</population>
        <group_list>
          <group group_id="O1">
            <title>NIRS Monitoring</title>
            <description>These infants will be monitored with NIRS&#xD;
Near Infrared Spectroscopy: Application of regional NIRS sensors to brain and kidney sites in the first 48 hours after birth to monitor regional tissue oxygenation for the first 7 days of age.</description>
          </group>
        </group_list>
        <measure>
          <title>Renal NIRS Values 2 Hours After Caffeine</title>
          <description>Renal NIRS values 2 hours after caffeine broken down by baseline average</description>
          <population>Out of 35 enrolled participants, 32 participants received total 156 doses of caffeine. Giving Caffeine was at the discretion of the attending physician.&#xD;
This analysis is done by the dose of caffeine, and not the participant. Each row shows the number of doses given in that baseline percentage.&#xD;
The caffeine doses have been de-identified from the participants so the number of participants in each row cannot be calculated from the currently recorded data.</population>
          <units>percentage saturation</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>caffeine doses</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>caffeine doses</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Doses with baseline &lt;20% (12 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.15" lower_limit="15.11" upper_limit="21.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 20-29.99% (16 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.66" lower_limit="32.83" upper_limit="47.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 30-39.99% (18 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.06" lower_limit="26.85" upper_limit="49.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 40-49.99% (13 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.96" lower_limit="43.6" upper_limit="56.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 50-59.99% (21 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.81" lower_limit="49.06" upper_limit="63.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline &gt;60% (76 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="76"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.51" lower_limit="62.63" upper_limit="78.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Control group is secondary outcome #4, baseline values before caffeine dose</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Mann Whitney U non parametric test</non_inferiority_desc>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>A-priori threshold p&lt;0.05 for 'subgroup 20-29.99%' vs 'baseline value before caffeine dose'.</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Renal NIRS Values 3 Hours After Caffeine</title>
        <description>Renal NIRS values 3 hours after caffeine broken down by baseline average</description>
        <time_frame>At 3 hours after caffeine dose</time_frame>
        <population>Out of 35 enrolled participants, 32 participants received total 156 doses of caffeine. Giving Caffeine was at the discretion of the attending physician.&#xD;
This analysis is done by the dose of caffeine, and not the participant. Each row shows the number of doses given in that baseline percentage.&#xD;
The caffeine doses have been de-identified from the participants so the number of participants in each row cannot be calculated from the currently recorded data.</population>
        <group_list>
          <group group_id="O1">
            <title>NIRS Monitoring</title>
            <description>These infants will be monitored with NIRS&#xD;
Near Infrared Spectroscopy: Application of regional NIRS sensors to brain and kidney sites in the first 48 hours after birth to monitor regional tissue oxygenation for the first 7 days of age.</description>
          </group>
        </group_list>
        <measure>
          <title>Renal NIRS Values 3 Hours After Caffeine</title>
          <description>Renal NIRS values 3 hours after caffeine broken down by baseline average</description>
          <population>Out of 35 enrolled participants, 32 participants received total 156 doses of caffeine. Giving Caffeine was at the discretion of the attending physician.&#xD;
This analysis is done by the dose of caffeine, and not the participant. Each row shows the number of doses given in that baseline percentage.&#xD;
The caffeine doses have been de-identified from the participants so the number of participants in each row cannot be calculated from the currently recorded data.</population>
          <units>percentage saturation</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>caffeine doses</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>caffeine doses</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Doses with baseline &lt;20% (12 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.3" lower_limit="16.09" upper_limit="30.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 20-29.99% (16 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.12" lower_limit="33.25" upper_limit="41.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 30-39.99% (18 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.4" lower_limit="30.55" upper_limit="51.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 40-49.99% (13 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.6" lower_limit="47.21" upper_limit="54.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 50-59.99% (21 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.05" lower_limit="53.22" upper_limit="63.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline &gt;60% (76 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="76"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.55" lower_limit="61.92" upper_limit="74.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Comparison group is Secondary outcome #4, baseline caffeine values by subgroup</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Mann-Whitney U non parametric t test</non_inferiority_desc>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>A-priori threshold p&lt;0.05 for 'subgroup 20-29.99%' vs 'baseline value before caffeine dose'.&#xD;
A-priori threshold p&lt;0.05 for 'subgroup &gt;60% ' vs 'baseline value before caffeine dose'.</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Renal NIRS Values 4 Hours After Caffeine</title>
        <description>Renal NIRS values 4 hours after caffeine broken down by baseline average</description>
        <time_frame>At 4 hours after caffeine dose</time_frame>
        <population>Out of 35 enrolled participants, 32 participants received total 156 doses of caffeine. Giving Caffeine was at the discretion of the attending physician.&#xD;
This analysis is done by the dose of caffeine, and not the participant. Each row shows the number of doses given in that baseline percentage.&#xD;
The caffeine doses have been de-identified from the participants so the number of participants in each row cannot be calculated from the currently recorded data.</population>
        <group_list>
          <group group_id="O1">
            <title>NIRS Monitoring</title>
            <description>These infants will be monitored with NIRS&#xD;
Near Infrared Spectroscopy: Application of regional NIRS sensors to brain and kidney sites in the first 48 hours after birth to monitor regional tissue oxygenation for the first 7 days of age.</description>
          </group>
        </group_list>
        <measure>
          <title>Renal NIRS Values 4 Hours After Caffeine</title>
          <description>Renal NIRS values 4 hours after caffeine broken down by baseline average</description>
          <population>Out of 35 enrolled participants, 32 participants received total 156 doses of caffeine. Giving Caffeine was at the discretion of the attending physician.&#xD;
This analysis is done by the dose of caffeine, and not the participant. Each row shows the number of doses given in that baseline percentage.&#xD;
The caffeine doses have been de-identified from the participants so the number of participants in each row cannot be calculated from the currently recorded data.</population>
          <units>percentage saturation</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>caffeine doses</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>caffeine doses</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Doses with baseline &lt;20% (12 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.98" lower_limit="15.01" upper_limit="22.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 20-29.99% (16 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.64" lower_limit="33.55" upper_limit="48.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 30-39.99% (18 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.71" lower_limit="29.96" upper_limit="54.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 40-49.99% (13 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.47" lower_limit="45.52" upper_limit="53.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 50-59.99% (21 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.78" lower_limit="52.05" upper_limit="64.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline &gt;60% (76 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="76"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.19" lower_limit="62.12" upper_limit="79.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Comparison group is secondary outcome #4, baseline values before caffeine dose</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>A-priori threshold p&lt;0.05 for 'subgroup 20-29.99%' vs 'baseline value before caffeine dose'.</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Renal NIRS Values 6 Hours After Caffeine</title>
        <description>Renal NIRS values 6 hours after caffeine broken down by baseline average</description>
        <time_frame>At 6 hours after caffeine dose</time_frame>
        <population>Out of 35 enrolled participants, 32 participants received total 156 doses of caffeine. Giving Caffeine was at the discretion of the attending physician.&#xD;
This analysis is done by the dose of caffeine, and not the participant. Each row shows the number of doses given in that baseline percentage.&#xD;
The caffeine doses have been de-identified from the participants so the number of participants in each row cannot be calculated from the currently recorded data.</population>
        <group_list>
          <group group_id="O1">
            <title>NIRS Monitoring</title>
            <description>These infants will be monitored with NIRS&#xD;
Near Infrared Spectroscopy: Application of regional NIRS sensors to brain and kidney sites in the first 48 hours after birth to monitor regional tissue oxygenation for the first 7 days of age.</description>
          </group>
        </group_list>
        <measure>
          <title>Renal NIRS Values 6 Hours After Caffeine</title>
          <description>Renal NIRS values 6 hours after caffeine broken down by baseline average</description>
          <population>Out of 35 enrolled participants, 32 participants received total 156 doses of caffeine. Giving Caffeine was at the discretion of the attending physician.&#xD;
This analysis is done by the dose of caffeine, and not the participant. Each row shows the number of doses given in that baseline percentage.&#xD;
The caffeine doses have been de-identified from the participants so the number of participants in each row cannot be calculated from the currently recorded data.</population>
          <units>percentage saturation</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>caffeine doses</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>caffeine doses</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Doses with baseline &lt;20% (12 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.4" lower_limit="15.03" upper_limit="23.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 20-29.99% (16 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.18" lower_limit="24.22" upper_limit="43.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 30-39.99% (18 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.62" lower_limit="33.47" upper_limit="51.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 40-49.99% (13 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.97" lower_limit="44.94" upper_limit="57.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline 50-59.99% (21 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.8" lower_limit="43.07" upper_limit="65.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Doses with baseline &gt;60% (76 caffeine doses)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="32"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>caffeine doses</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="76"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.09" lower_limit="62.65" upper_limit="79.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Comparison group is Secondary Outcome #4, baseline before dose of caffeine.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Mann Whitney U non-parametric t-test</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>A-priori threshold p&lt;0.05 for 'subgroup 20-29.99%' vs 'baseline value before caffeine dose'.</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>7 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>No Acute Kidney Injury (AKI)</title>
          <description>Infants with No AKI diagnosis.&#xD;
These infants will be monitored with NIRS&#xD;
Near Infrared Spectroscopy: Application of regional NIRS sensors to brain and kidney sites in the first 48 hours after birth to monitor regional tissue oxygenation for the first 7 days of age.</description>
        </group>
        <group group_id="E2">
          <title>Acute Kidney Injury (AKI)</title>
          <description>Infants diagnosed with AKI.&#xD;
These infants will be monitored with NIRS&#xD;
Near Infrared Spectroscopy: Application of regional NIRS sensors to brain and kidney sites in the first 48 hours after birth to monitor regional tissue oxygenation for the first 7 days of age.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Matthew Harer</name_or_title>
      <organization>University of Wisconsin, Madison</organization>
      <phone>608-417-6236</phone>
      <email>mwharer@wisc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

